GRI Bio, Inc. (GRI)
(Delayed Data from NSDQ)
$1.32 USD
+0.04 (3.13%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $1.32 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value A Growth A Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, GRI Bio, Inc. has a market cap of $3.20M, which represents its share price of $1.28 multiplied by its outstanding shares number of 2.50M. As a small-cap company, GRI's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
GRI 1.32 +0.04(3.13%)
Will GRI be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for GRI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for GRI
GRI Stock Down on Public Offering Despite Encouraging IPF Study Data
GRI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for GRI
Crude Oil Falls 1%; Meta Earnings Top Views
12 Health Care Stocks Moving In Thursday's Intraday Session
Nasdaq Surges Over 1%; Microsoft Posts Upbeat Earnings
GRI Bio (GRI) Reports Promising Interim Results from Phase 2a Study on IPF